Gene therapy maker bluebird to go private in discounted deal amid cash crunch Gene therapy maker bluebird bio on Friday agreed to be taken private by Carlyle Group and SK Capital Partners at a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback